Microsize is a US-based pharmaceutical contract development and manufacturing organization that micronizes and controls particle size to improve the dissolution and bioavailability of challenging drug ingredients. With more than 30 years of specialized experience, the company has processed hundreds of APIs across over 10,000 production campaigns and operates three FDA-inspected facilities totaling more than 100,000 square feet near Philadelphia. Microsize also designs the micronization equipment it uses and supports highly potent compounds with dedicated containment systems from development through commercial supply.
US FDA Title 21 CFR Parts 210/211 GMPs
compliance_program
cGMP
compliance_program